UNITED THERAPEUTICS Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Silver Spring, MD
SEC filing record 1 source field available
Fiscal year end
31 December
UNITED THERAPEUTICS Corp has filed 4,384 SEC EDGAR filings since 16 Apr 1999

SEC filing history

Showing 576-600 of 1,000 matching filings.

Per page
25
Current page
24
DEFA14A File 000-26301

DEFA14A

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-26301

DEFINITIVE PROXY STATEMENT

Filing date
29 Apr 2025
Reporting date
26 Jun 2025
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Apr 2025
Reporting date
21 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
21 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Apr 2025
Reporting date
17 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Apr 2025
Reporting date
14 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
14 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2025
Reporting date
07 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
07 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Apr 2025
Reporting date
03 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
03 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Mar 2025
Reporting date
24 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
24 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2025
Reporting date
19 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
19 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Mar 2025
Reporting date
07 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Mar 2025
Reporting date
10 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
10 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2025
Reporting date
06 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
28 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .